Hépato-Gastro & Oncologie Digestive
MENUManagement of digestive polyposis and predisposition syndromes for colorectal cancer. What is new in 2021? Volume 28, issue 9, November 2021
Figures
Tables
- Key words: familial adenomatous polyposis, Lynch syndrome, Lynch like syndrome, Hamarthomatous polyposis, Peutz-Jeghers syndrome, Juvenile polyposis, Cowden Disease, Proofreading polymerase syndromes
- DOI : 10.1684/hpg.2021.2242
- Page(s) : 1112-32
- Published in: 2021
Most of colorectal cancers (CRC) develop in a sporadic context. However, it is estimated that around 35% of CRCs have a familial component and that 2 to 5% occur as part of a genetic predisposition. Among this population, we can distinguish between two phenoptypes: The so-called “polyposis” syndromes and those called “non-polyposis” syndromes, mainly represented by the Lynch syndrome. The particularity of these syndromes is that they present a broad carcinological spectrum, affecting both the colon but also other digestive or extra digestive organs (endometrium, ovary, etc.). The identification and management of these syndromes requires a multidisciplinary approach, the cornerstone of which is based on consultation of oncogenetics accessible via one of the 17 regional or inter-regional networks of the oncogenetics system (INCa 2012). These networks make it possible to organize and coordinate manadgment, by developing specific personalized follow-up plans (PPS). Digestive endoscopy plays a central role in this, ensuring both a cancer screening and prevention role. In this update, we will discuss the latest management recommendations, syndrome by syndrome.